Transhinlactones and their derivatives are a class of natural products isolated from Salvia miltiorrhiza, commonly known as Danshen. These compounds exhibit significant biological activities including anti-inflammatory, antioxidant, and anticancer effects. Transhinlactone A, for instance, has been shown to inhibit the growth of various cancer cells by modulating signaling pathways involved in cell proliferation and apoptosis. Additionally, these derivatives possess potential applications in cardiovascular disease treatment due to their ability to regulate lipid metabolism and improve blood flow. The structural diversity within this class of compounds allows for the development of novel therapeutic agents with enhanced efficacy and reduced side effects compared to traditional Danshen extract.